Cargando…

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is present in approximately one-third of all congestive heart failure (CHF) patients, and is a key cause of underprescription and underdosing of β-blockers, largely owing to concerns about precipitating respiratory deterioration. For these rea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubota, Yoshiaki, Asai, Kuniya, Furuse, Erito, Nakamura, Shunichi, Murai, Koji, Tsukada, Yayoi Tetsuou, Shimizu, Wataru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356705/ https://www.ncbi.nlm.nih.gov/pubmed/25784798 http://dx.doi.org/10.2147/COPD.S79942

Ejemplares similares

COPD advances in left ventricular diastolic dysfunction
por: Kubota, Yoshiaki, et al.
Publicado: (2016)

Status of Medical Care and Management Requirements of Elderly Patients With Heart Failure in a Comprehensive Community Health System　― Survey of General Practitioners’ Views ―
por: Tsukada, Yayoi Tetsuou, et al.
Publicado: (2021)

Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure
por: Kubota, Yoshiaki, et al.
Publicado: (2017)

Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2021)

Validation of wearable textile electrodes for ECG monitoring
por: Tsukada, Yayoi Tetsuou, et al.
Publicado: (2019)

Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study
por: Nakamura, Shunichi, et al.
Publicado: (2014)

Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance
por: Suzuki, Keishi, et al.
Publicado: (2016)

Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale
por: Kubota, Yoshiaki, et al.
Publicado: (2018)

Clinical features and long-term prognosis of patients with congestive heart failure taking tolvaptan: a comparison of patients with preserved and reduced left ventricular ejection fraction
por: Seki, Toshiki, et al.
Publicado: (2021)

How to Assess the Degree of Pulmonary Congestion in Patients with Congestive Heart Failure
por: Imamura, Teruhiko
Publicado: (2023)

Effect of Empagliflozin in Preventing Progression of Renal Dysfunction in Diabetic Patients With Compensated Heart Failure　― Reply ―
por: Shirakabe, Akihiro, et al.
Publicado: (2021)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Effect of Empagliflozin Versus Placebo on Plasma Volume Status in Patients with Acute Myocardial Infarction and Type 2 Diabetes Mellitus
por: Hoshika, Yu, et al.
Publicado: (2021)

Empagliflozin confers reno‐protection in acute myocardial infarction and type 2 diabetes mellitus
por: Mozawa, Kosuke, et al.
Publicado: (2021)

Lung sound patterns of exacerbation of congestive heart failure, chronic obstructive pulmonary disease and asthma
por: Bartter, T, et al.
Publicado: (2008)

Impacts of Comorbid Chronic Obstructive Pulmonary Disease and Congestive Heart Failure on Prognosis of Critically Ill Patients
por: Dai, Ying, et al.
Publicado: (2020)

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial
por: Shimizu, Wataru, et al.
Publicado: (2020)

Awareness and Feasibility of Women Chairing Cardiology Sessions in Scientific Meetings: A Nationwide Survey by the Japanese Circulation Society
por: Nakayama, Atsuko, et al.
Publicado: (2022)

Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes
por: Nishida, Yayoi, et al.
Publicado: (2012)

Worsening renal failure in patients with acute heart failure: the importance of cardiac biomarkers
por: Shirakabe, Akihiro, et al.
Publicado: (2019)

Can Peak Expiratory Flow Measurements Differentiate Chronic Obstructive Pulmonary Disease from Congestive Heart Failure?
por: Gough, John E., et al.
Publicado: (2012)

Respiratory syncytial virus–associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive heart failure
por: Falsey, Ann R, et al.
Publicado: (2018)

More Impaired Dynamic Ventilatory Muscle Oxygenation in Congestive Heart Failure than in Chronic Obstructive Pulmonary Disease
por: Chuang, Ming-Lung, et al.
Publicado: (2019)

Relationship of maximum walking speed with peak oxygen uptake and anaerobic threshold in male patients with heart failure
por: Koen, Masahiro, et al.
Publicado: (2023)

Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure
por: Shirakabe, Akihiro, et al.
Publicado: (2018)

Pulmonary Congestion Assessment in Heart Failure: Traditional and New Tools
por: Pirrotta, Filippo, et al.
Publicado: (2021)

Congestive heart failure presenting as diffuse pulmonary nodules on CT
por: Malone, Ashlee, et al.
Publicado: (2021)

Noninvasive assessment of pulmonary congestion in heart failure: Need of the hour
por: Deora, Surender, et al.
Publicado: (2023)

Congestive heart failure
por: Zhao, Xuan
Publicado: (2019)

Modification of ALPPS to avoid ischemia and congestion after stage 1: a case report
por: Ishihara, Mai, et al.
Publicado: (2022)

Effort Oxygen Saturation and Effort Heart Rate to Detect Exacerbations of Chronic Obstructive Pulmonary Disease or Congestive Heart Failure
por: Gálvez-Barrón, César, et al.
Publicado: (2019)

Prevalence and Patterns of Obstructive Sleep Apnea in Asian Indians With Congestive Heart Failure
por: Bhalla, Sukriti, et al.
Publicado: (2020)

The Interplay between Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease, and Congestive Heart Failure: Time to Collectively Refer to Them as Triple Overlap Syndrome?
por: Banjade, Prakash, et al.
Publicado: (2023)

A case of type 1 facioscapulohumeral muscular dystrophy (FSHD) with restrictive ventilatory defect and congestive heart failure
por: Morimoto, Nobutoshi, et al.
Publicado: (2020)

AT(1) receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats
por: Kratky, Vojtech, et al.
Publicado: (2021)

Pacing in congestive heart failure
por: Morris-Thurgood, Jayne A, et al.
Publicado: (2000)

The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit
por: Kargin, Feyza, et al.
Publicado: (2014)

Congestive heart failure : mechanisms, evaluation, and treatment /
Publicado: (1976)

Sphingobacterium spiritivorum bacteremia due to cellulitis in an elderly man with chronic obstructive pulmonary disease and congestive heart failure: a case report
por: Hibi, Arata, et al.
Publicado: (2017)

Association of congestion with worsening renal function in acute decompensated heart failure according to age
por: Odajima, Susumu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q0q2bv5q87mn89llbs4tofkfk9